Академический Документы
Профессиональный Документы
Культура Документы
following a bout with bronchitis. This is really a specific type of pneumonia that is localized in the bronchioles and surrounding
alveoli. This article provides a general overview of this condition, including symptoms and treatment options for those who have been
diagnosed with bronchopneumonia. The most common pneumonia-causing bacterium in adults is Streptococcus pneumoniae
(pneumococcus)
PATHOPHYSIOLOGY
↓
Inflammation occurs
↓
Alveolar fluid increase
↓
Ventilation decreases as secretion thicken
↓
Bronchopneumonia
Empyema Pleurisy
(collection of pus & liquid (Inflammation of membrane)
From infected tissue)
Lung Abscess
(collection of pus, inflammation
& destruction of tissue)
↓
Cancer of the lung
↓
Death
Pathophysiology:
Inoculation of the respiratory tract by infectious organisms leads to an acute inflammatory response in the host that is typically 1-2
weeks in duration. This inflammatory response differs according to the type of infectious agent present.
Viral Infection
These are characterized by the accumulation of mononuclear cells in the submucosa and perivascular space, resulting in partial
obstruction of the airway. They clinically manifest as wheezing and crackles.
Disease progresses when the alveolar type II cells lose their structural integrity and surfactant production is diminished, a hyaline
membrane forms, and pulmonary edema develops.
Bacterial Infection
The alveoli fill with proteinaceous fluid, which triggers a brisk influx of red blood cells and polymorphonuclear cells (red
hepatization) followed by the deposition of fibrin and the degradation of inflammatory cells (gray hepatization).
During resolution, intra - alveolar debris is ingested and removed by the alveolar macrophages. This consolidation leads to decreased
air entry and dullness to percussion. Inflammation in the small airways leads to crackles. Wheezing is less common than in viral
infections.
Inflammation and pulmonary edema resulting from these infections causes the lungs to become stiff and less distensible, thereby
decreasing tidal volume. The patient must increase his respiratory rate to maintain adequate ventilation.
DRUG STUDY
Dosage:
Q4h/Q6h
Available forms:
Tablet and suppository
Dosage:
125 mg/q6
Classification:
Cephalosporin, Second
Generation
Dosage:
250 mg
Classification:
Cephalosporin, Third
Generation